The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 23.70
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 0.30 (1.266%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.00
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Activities and Cash Flow Report

27 Oct 2022 07:05

RNS Number : 3079E
Atlantic Lithium Limited
27 October 2022
 

27 October 2022

Corporate Update

 

Quarterly Activities and Cash Flow Report

for the quarter ended 30 September 2022

 

Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTC: ALLIF, "Atlantic Lithium" or the "Company"), the funded African-focussed lithium exploration and development company targeting to deliver Ghana's first lithium mine, is pleased to present its Quarterly Report for the quarter ended 30 September 2022.

 

The Quarterly Report for the quarter ended 30 September 2022 can be viewed and is available via this link:

http://www.rns-pdf.londonstockexchange.com/rns/3079E_1-2022-10-27.pdf

 

Quarterly Highlights:

 

Ewoyaa Lithium Project, Ghana

 

· Delivered robust Pre-Feasibility Study ("PFS"), with highlights including:

Post-tax NPV8 of US$1.33bn with free cash flow of US$2bn from Life of Mine ("LOM") revenues of US$4.84bn.

Internal rate of return of 224% and payback less than five months, with an average LOM EBITDA of $248 million per annum.

Maiden Ore Reserve of 18.9Mt at 1.24% Li2O declared, demonstrating sound resource to reserve conversion.

12.5-year mine life, 2Mtpa conventional dense media separation ("DMS") processing facility with average 255,000tpa 6% lithium spodumene concentrate ("SC6") production.

 

· Received assay results for approximately 6,900m of Reverse Circulation ("RC") drilling completed at the Ewoyaa Main and Grasscutter North targets as part of the planned 37,000m resource evaluation and exploration RC and diamond core drilling ("DD") programme (see releases dated 19 July and 2nd August 2022).

o The programme, which was completed post-period end, was extended by 10,000m for geotechnical, metallurgical, hydrogeological and exploration drilling to a total of 47,000m.

 

Corporate Highlights

 

· Commenced trading on the Australian Securities Exchange ("ASX") under the ticker 'A11'.

· Cash on hand at end of quarter of A$23.4 million.

 

Commenting on the Company's latest progress, Neil Herbert, Executive Chairman of Atlantic Lithium, said:

 

"We are pleased to be releasing the Company's quarterly report for the period ended 30 September 2022 - the first announcement of this kind following Atlantic Lithium's Admission on the ASX.

 

"The publishing of the Pre-Feasibility Study in September marked a significant milestone in the Ewoyaa Lithium Project's journey towards production. We have continued to build on this progress post-period end through the submission of an application for a mining licence to the Minerals Commission of Ghana and the completion of the extended drilling programme at the Project. Work is now ongoing to deliver a further Resource upgrade at Ewoyaa in the final quarter of the year or early in 2023.

 

"We also believe that the Company's listing on the ASX during the period will enable us to extend the Company's shareholder base, enable wider trading and offer greater liquidity for Atlantic Lithium shares. With a number of lithium companies on the ASX attracting significant investor interest recently, we hope that the listing will be a step towards achieving a more attractive valuation with respect to our industry-leading Ewoyaa Project. As an Australian-headquartered company, the listing also enables closer communication with our existing investor base in Australia.

 

"We look forward to providing further updates on our progress in due course."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For any further information, please contact:

 

Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

www.atlanticlithium.com.au

Tel: +61 2 8072 0640

 

 

atlantic@yellowjerseypr.com

 

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

 

Tel: +44 (0)20 3470 0470

Canaccord Genuity Limited

Joint Company Broker

Raj Khatri

James Asensio

Harry Rees

 

Tel: +44 (0) 20 7523 4500

 

Liberum Capital Limited

Joint Company Broker

Scott Mathieson

Edward Thomas

Kane Collings

 

Tel: +44 (0) 20 3100 2000 

 

Yellow Jersey PR Limited

Henry Wilkinson

Dominic Barretto

James Lingfield

Tel: +44 (0)20 3004 9512

 

Notes to Editors:

 

About Atlantic Lithium

www.atlanticlithium.com.au

 

Atlantic Lithium (formerly "IronRidge Resources") is an AIM and ASX-listed lithium exploration and development company advancing a portfolio of lithium projects and licenses in Ghana and Côte d'Ivoire through to production.

 

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium producing mine. The Company signed a funding agreement with Piedmont Lithium Inc. for US$103m towards the development of the Ewoyaa Project. Based on the Pre-Feasibility Study, the Ewoyaa Project has indicated Life of Mine revenues exceeding US$4.84bn, producing a spodumene concentrate via simple gravity only process flowsheet.

 

Atlantic Lithium holds 560km2 & 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licenses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBOORUWURURA
Date   Source Headline
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSNotice of Results
8th Jan 20137:00 amRNSFirst Half Trading Update
23rd Nov 20123:18 pmRNSResult of AGM
31st Oct 20127:00 amRNSBoard Appointment
29th Oct 20127:00 amRNSNotice of AGM
18th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:56 amRNSNotification of Major Interest in Shares
1st Oct 20121:14 pmRNSTrading Update
19th Sep 20124:01 pmRNSExercise of Options
15th Aug 20124:35 pmRNSGrant of Share Options to Directors
15th Aug 20127:05 amRNSAnnual Accounts 2012
13th Aug 20123:27 pmRNSNotification of Major Interest in Shares
13th Aug 201210:15 amRNSNotification of Major Interest in Shares
31st Jul 20127:05 amRNSRecord Final Results FYE 31 May 2012
31st Jul 20127:00 amRNSAcquisition of RealTime Health

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.